While this treatment had minimal direct effect on cancer cells, it led to a reduction of serum levels of IL-6 and EGF, known CAF secreted factors and reduced tumour growth was mediated by a reduction of CXCL12 and destruction of ECM (90) (Figure 2B). This evidence concerns the gene CXCL12 and cancer.